The sleep apnea feature of the Samsung Galaxy Watch has been approved by the US FDA for the first time

On February 10, Samsung Electronics announced that the sleep apnea function on the Samsung Health Monitor App has been authorized by the US Food and Drug Administration (FDA). This is the first such feature authorized by the U.S. Food and Drug Administration following the approval of the Korea Food and Drug Safety Ministry (MFDS) in October last year.

The sleep apnea feature will enable users over the age of 22 who have not been diagnosed with sleep apnea to detect signs of moderate to severe obstructive sleep apnea (OSA), a common chronic sleep condition that is often undiagnosed and untreated, during a two-night monitoring period. To use the feature, users can simply track their sleep twice over a ten-day period, lasting more than four hours.

OSA can cause a person to stop breathing during sleep, often resulting in disrupted oxygen supply, reduced sleep quality, and daytime fatigue. Untreated sleep apnea increases the risk of cardiovascular disease, such as high blood pressure, coronary artery disease, heart failure, arrhythmias, and stroke.

According to the National Sleep Foundation (NSF), approximately 25 percent of men and 10 percent of women in the United States suffer from OSA. The new feature on Samsung’s Health monitoring app is expected to help more people proactively detect moderate or severe OSA and therefore seek medical care to reduce the likelihood of health-related complications.

At present, Samsung has not disclosed whether this function will be compatible with the old Galaxy Watch, interested friends can follow the follow-up report of the Igeekphone.

Read more